Steve founded MVM in 1997. Prior to setting up MVM, he was responsible for healthcare investments at Saunders, Karp & Megrue. He was also involved in founding several US biotechnology companies and was the first investor in and acting CEO of UpToDate, Inc.

Steve previously worked as an Investigator of the Howard Hughes Medical Institute at Yale and was an Associate Physician at Brigham and Women’s Hospital. He has published extensively on the molecular genetics of human disease. Steve practiced medicine at the John Radcliffe, Churchill, Guys, St. Thomas’s, and Hammersmith Hospitals and the Institute of Neurology, Queen Square before taking up research at Oxford University. He holds a BA in Natural Sciences from Cambridge and an DM from Oxford.

Steve is a member of the board of BioProtect, Ossio, eZono AG, Vital Connect, Inc., and AccuVein, Inc. He was previously a director of Ambio, Inc., Beacon Endoscopic Ltd, BioVex Group, Inc., Cara Therapeutics, Inc., Cheetah Medical Inc., Clavis AS., Gendaq Ltd, Momenta Pharmaceuticals, Inc., Pulmagen Therapeutics Ltd., Sangamo Biosciences, Inc., UpToDate, Inc., Vascular Pathways, Inc., Xention Ltd., Patient Connect Ltd and Zipline Medical, Inc

Latest news

Optinose’s XHANCE® Approved by FDA for Chronic Rhinosinusitis without Nasal Polyps
March 15, 2024

Full release here: Optinose’s XHANCE® Approved by FDA for Chronic Rhinosinusitis without Nasal Polyps

GT Medical Technologies Names Per Langoe As CEO
February 20, 2024

Full release here: GT Medical Technologies, Inc. Names Per Langoe As CEO

MVM invests in icotec
January 24, 2024

ALTSTAETTEN, Switzerland and EAST HARTFORD, Conn., Jan. 24, 2024 /PR Newswire/ — icotec ag, the leading company in the field of innovative spinal […]

MVM invests in Gynesonics
November 1, 2023

REDWOOD CITY, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) — Gynesonics® Inc., a women’s healthcare company focused on the development of […]

SkyCell Featured in TechCrunch
October 31, 2023

Full release here: SkyCell raises $57M at a $600M valuation to build smart containers for pharmaceutical transport | TechCrunch

MVM invests in BioProtect
September 27, 2023

TZUR IGAL, Israel, Sept. 27, 2023 /PRNewswire/ — BioProtect Ltd, a private Med Tech company focused on providing innovative, biodegradable spacing solutions, announced today the […]

VitalConnect Secures over $30 Million in Oversubscribed Series F Financing
July 18, 2023

SAN JOSE, Calif.–(BUSINESS WIRE)–VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced closing on an oversubscribed […]

MVM invests in CurvaFix
July 14, 2023

BELLEVUE, Wash.–(BUSINESS WIRE)–CurvaFix, Inc., a developer of medical devices to repair fractures in curved bones, today announced the close of […]

Vertos Medical Secures $26 Million to Expand Commercialization Efforts and Develop Breakthrough Treatments for Chronic Low Back Pain
June 7, 2023

ALISO VIEJO, Calif., June 7, 2023 /PRNewswire/ — Vertos Medical Inc., a leader in the development of innovative, minimally invasive treatments for […]

eXmoor pharma completes $35 million Series A to expand cell and gene therapy manufacturing capabilities
May 30, 2023

New GMP facility to complete eXmoor’s transition from consultancy to one-stop global cell and gene therapy partner Bristol, UK, May […]